Menu

What we do

Who we are

About Team Contact Newsletter Sign Up

Logins

FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib

Windham Capital Partners

|

April 1, 2026

Explore More

No items found.

Portfolio About Team News Contact Us Newsletter Sign Up Privacy Policy Terms of Use

Windham Capital Partners
500 Fifth Avenue, Ste 3600
New York, NY 10110

TEL: 212.235.1091

EMAIL: info@windhamcap.com

Windham Capital Partners © 2022